by Camille Belliard: This week’s journal club discusses a landmark first-in-human study published in Cell (2024) investigating autologous transplantation of chemically induced pluripotent stem cell-derived islets (CiPSC-islets) for type 1 diabetes (T1D).
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed